Laserfiche WebLink
Administrator may institute such changes to calculation of QPA without further notice; <br /> otherwise,the Parties shall mutually agree in writing whether and how Claim Administrator <br /> shall calculate QPA for Claims beginning on or after November 1,2024." <br /> 2. Section 7 "DEFINITIONS", 7.8 "Claim Payment" is amended by adding the following sentence <br /> at the end of the current language: <br /> 'The term "Claim Payment" also can include payments for services to Employer's Vendor(s) or <br /> Claim Administrator's subcontractors." <br /> 3. Section 7 "DEFINITIONS", 7.27 "Net Claim Payment" is amended by adding the following <br /> sentence at the end of the current language: <br /> "The term"Net Claim Payment"also can include payments for services to Employer's Vendor(s)or <br /> Claim Administrator's subcontractors." <br /> 4. EXHIBIT 1 —CLAIM ADMINISTRATOR SERVICES, "THE FOLLOWING IF ELECTED ON THE <br /> MOST CURRENT BPA," "FLEXACCESS" is amended by replacing the first sentence of the <br /> paragraph with the following: <br /> "Claim Administrator or its designee(s) will proactively enroll Covered Persons into a program <br /> designed to lower prescription drug costs through manufacturer copay assistance programs." <br /> 5. EXHIBIT 1 —CLAIM ADMINISTRATOR SERVICES, "THE FOLLOWING IF ELECTED ON THE <br /> MOST CURRENT BPA," "GENE THERAPY SOLUTION: CELL AND GENE NAVIGATION & <br /> GENE OUTCOMES" is added and should read as follows: <br /> "GENE THERAPY SOLUTION: CELL AND GENE NAVIGATION &GENE OUTCOMES <br /> Provide (1) the mutually agreed upon member navigation services for Covered Persons who are <br /> eligible to receive gene and cellular therapy services to assist such Covered Persons with obtaining <br /> services at a participating Provider, and (2) access to payments resulting from outcome-based <br /> agreements held,directly or indirectly,with Manufacturers of gene and cellular therapy drugs.Claim <br /> Administrator may receive payments in the event that select gene or cellular therapy treatments fail <br /> to meet the outcome-based metrics set forth in the outcome-based agreement with the <br /> Manufacturer.Claim Administrator will pay Employer the agreed upon percentage of the outcome <br /> based payment set forth in the BPA of the outcome based payment received by Claim <br /> Administrator. Notwithstanding the foregoing, the Employer will not be eligible to receive any <br /> payments received from outcome-based agreements after final settlement, following the <br /> termination of this Agreement and the completion of any applicable Run-Off period." <br /> 6. EXHIBIT 2 — FEE SCHEDULE AND FINANCIAL TERMS, Section 3 "COMPENSATION TO <br /> CLAIM ADMINISTRATOR" is amended by adding the following Section 3.8 "Shared Savings <br /> Programs": <br /> "3.8 Shared Savings Programs. Claim Administrator may offer programs that include <br /> compensation to the Claim Administrator based on shared savings as may be described in <br /> the most recent BPA or in another mutually agreed writing between the Parties. In general, <br /> these "Shared Savings Programs" measure savings as reductions in expected or actual <br /> Claims costs by reason of the Employer's adoption of the program. Employer <br /> acknowledges and agrees that Claim Administrator does not act as a fiduciary under <br /> ERISA when engaging in activities related to Shared Savings Programs under this Section <br /> because such activities do not constitute an exercise of discretion or control over Plan <br /> assets or Plan administration." <br /> IL Gen Med-CF Non-ERISA ASA Amendment Rev.7.24 <br /> 2 <br /> Proprietary and Confidential Information of Claim Administrator <br /> Not for use or disclosure outside Claim Administrator,Employer,their respective affiliated companies,and <br /> third-party representatives,except with written permission of Claim Administrator. <br />